RNAi Therapeutics Market Latest Trends and Future Growth Study by 2033
The RNAi Therapeutics Market involves the development and commercialization of RNA interference-based treatments that silence specific genes responsible for disease progression. This innovative sector encompasses small interfering RNA (siRNA) and microRNA (miRNA) therapies, targeting a range of conditions from genetic disorders to cancers. It represents a frontier in precision medicine, offering potential for highly targeted, effective treatments with fewer side effects, thus transforming therapeutic landscapes and creating substantial opportunities for growth and investment.